English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduCOVID-19 vaccination has become a lightning rod for controversy over “vaccine passports” and claims of violations of medical privacy or individual rights. But as two experts explain, there’s a long history of efforts to protect the health of others by requiring individuals to provide proof of vaccination or of a past infection, or seek a medical or religious exception.
Tag: Vaccine
Ask your COVID-19 Vaccine Questions to CIHR’s Scientific Directors
This year, National Immunization Awareness Week (April 24-30) takes on a new level of significance, as we are in the midst of a pandemic the likes of which we have not before seen in our lifetime. Four of CIHR’s Scientific…
Unintended consequences: pediatrician cautions parents of the risks for missing important immunizations
Over the last year, parents have been doing their part to stay indoors and social distance to help stop the spread of COVID-19. But staying home has led to many children missing their annual check-ups and recommended vaccinations.
Story Tips from Johns Hopkins Experts on COVID-19
NEWS STORIES IN THIS ISSUE:
PREGNANT AFTER THE FIRST DOSE OF COVID-19 VACCINE — NOW WHAT?
STUDY SHOWS VACCINES MAY PROTECT AGAINST NEW COVID-19 STRAINS … AND MAYBE THE COMMON COLD
EXPANDED DASHBOARD TOOL RANKS ACCESSIBILITY OF STATE VACCINE WEBSITES
How do you plan a mass vaccination clinic? Iowa State students are working on it.
Iowa State’s COVID-19 vaccination plan ramps up starting April 20 as all adult students qualify and a mass vaccination clinic takes over State Gym’s three basketball courts. But it’s not as simple as setting up booths and having vaccines ready. That’s where industrial engineering students come in.
Rutgers Expert Addresses Questions on COVID-19 Vaccine Rollout and Variant Issues
Stanley H. Weiss, an epidemiologist in infectious and chronic diseases, and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health, talks about vaccine side effects, the hesitancy that still exists and why it is important to get vaccinated when it’s your turn.
Coronavirus Protein May Lead the Way to Future COVID-19 Vaccines
A new computational study suggests that a protein present in SARS-CoV-2, the virus that causes COVID-19, could be a target for future vaccines. The study is published ahead of print in the American Journal of Physiology-Lung Cellular and Molecular Physiology.
6 important things to know about your COVID-19 vaccine card
Everyone who gets vaccinated for COVID-19 in the U.S. receives a vaccine card. Sarah Lynch, clinical assistant professor of pharmacy practice at Binghamton University, State University of New York, offers insight into why vaccine cards are important and why you…
Palisades Medical Center COVID-19 Vaccine Efforts Support Community Health
Radames and Ana Arocho were all smiles when they arrived on the white school bus, and their enthusiasm was contagious.
Tip Sheet: New COVID-19 transmission study, returning to school, video of biorepositories — and a new weight loss study
SEATTLE — April 2, 2021 — Below are summaries of recent Fred Hutch research findings and other news. April is National Minority Health Month, with a focus on the disproportionate impacts of COVID-19 on communities of color. See more details below on related Fred Hutch programming.Save the date for our monthly public science event, “Science Says” on Tuesday, April 27.
Vaccine selfies: Promoting health safety outweighs potential feelings of FOMO
Early on in the COVID-19 pandemic, celebrities were as active as government and health officials in spreading the word about our health, using social media to encourage people to wash hands, wear masks and social distance. The “vaccine selfie,” as…
A Johns Hopkins University health care expert is available to offer perspective on the news that a mistake at a Johnson & Johnson factory producing the COVID-19 vaccine resulted in the loss of millions of doses.
A Johns Hopkins University health care expert is available to offer perspective on the news that a mistake at a Johnson & Johnson factory producing the COVID-19 vaccine resulted in the loss of millions of doses. Tinglong Dai is an…
Pfizer vaccine for kids may play ‘critical role’ in return to normalcy
Pfizer-BioNTech announced Wednesday its coronavirus vaccine is extremely effective in children ages 12 to15. No infections were found among children who received the vaccine in a recent clinical trial – news which may signal a speedy return to normalcy for…
UCLA to lead CDC-funded study testing effectiveness of vaccines on health workers
Researchers will study vaccinated and non-vaccinated health workers who get tested for the virus after experiencing common COVID-19 symptoms like fever, cough or a loss of sense of taste or smell. They will compare the incidence of positive tests and severity of illness in those who test positive.
Snapshot of COVID-19 Vaccine Intentions Highlights Challenges of Achieving Community Immunity Goals
Ahead of the first U.S. emergency use authorization for a COVID-19 vaccine, only half of Americans said they were likely to get vaccinated as soon as possible.
UVA, Va. Tech Virologists Develop Potential Broadly Protective Coronavirus Vaccines
A COVID-19 vaccine that could provide protection against both existing and future strains of the COVID-19 virus, and other coronaviruses, and cost about $1 a dose has shown promising results in early animal testing.
Widening political rift in U.S. may threaten science, medicine
Public participation is critical to the success of medical research. Yet recruiting volunteers for trials is increasingly challenging. New Washington University research suggests the widening ideological gap in the U.S. may be to blame.
New study: U.S. faces uphill struggle compared to U.K. in COVID-19 vaccination rates
Just 51% of Americans expressed a clear willingness to take the COVID-19 vaccine compared to 71% of residents in the United Kingdom, according to a new study conducted by Michigan State University’s Quello Center during the first nine months of the pandemic. “The data suggests that due to the confusion that existed in American politics, with even our leaders at the highest levels casting doubt on the pandemic, the scientific message was muddled in the U.S., whereas in the U.K. there was a unifying voice,” said Johannes Bauer, director of MSU’s Quello Center and co-principal investigator on the research.
@DrKatieFoss available for interviews on @POTUS plan to order 100 million more COVID-19 vaccine doses from Johnson & Johnson.
Murfreesboro, TN (March 11, 2021) – Middle Tennessee State University Professor Katherine Foss is available for interviews on President Biden’s plan to order 100 million more COVID-19 doses from Johnson & Johnson. “A one-dose vaccine is really the key to getting the…
University of Northern Colorado Immunology Expert Discusses COVID-19 Vaccines, Debunks Misinformation
Nick Pullen, Ph.D., an associate professor of Biological Sciences at the University of Northern Colorado, shares his expertise on the COVID-19 vaccines and debunks some of the myths surrounding them.
Mount Sinai Researchers Find that a Second Shot of COVID-19 Vaccine May Not be Necessary in Previously Infected Individuals
A single shot of one of the currently authorized COVID-19 vaccines may be sufficient to provide immunity to individuals who have previously been infected by the virus, thus eliminating the need for a second dose and helping to stretch severely limited vaccine supplies, a study from Mount Sinai has found
Story Tips from Johns Hopkins Experts on COVID-19
Since its opening in January 2016, the Johns Hopkins Capacity Command Center has helped the Johns Hopkins Health System manage hospital operations — notably the flow of patients. So when the COVID-19 pandemic and the first people with the illness came to the hospital, the capacity command center was ready to manage the influx of patients.
LifeBridge Health Launches Mobile Van to Provide Vulnerable Communities Access to COVID-19 Testing, Senior and Pediatric Care
LifeBridge Health recently announced the launch of its “Care Happens Here” mobile unit, which will bring a wide range of healthcare testing and treatment services, including COVID-19 vaccinations, to vulnerable communities throughout central Maryland.
Equitably Allocating COVID-19 Vaccine
Equitable implementation of COVID‐19 vaccine delivery is a national and global priority, with a strong focus on reducing existing disparities and not creating new disparities. But while a framework has been recognized for equitable allocation of COVID‐19 vaccine that acknowledges the rights and interests of sexual and gender minorities (SGM), it fails to identify strategies or data to achieve that goal.
COVID-19 Simulation Shows Importance of Continued Safety Efforts During Vaccine Distribution
Research out on the pre-publication website medRxiv shows how non-pharmaceutical interventions (NPIs) like mask wearing and physical distancing can help prevent spikes in COVID-19 cases as populations continue to get vaccinated.
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
SEATTLE — March 2, 2021 — Below are summaries of recent Fred Hutch research findings and other news with links for additional background and media contacts.March is Women’s History month. We’d like to honor Dottie Thomas, known as the “mother of bone marrow transplantation.” She spent years working as a research partner alongside her husband, Nobel Prize-winning Dr.
Goodbye UTIs: Duke scientists develop vaccine strategy for urinary tract infections
Duke researchers describe a new vaccination strategy that they think could re-program the body to fight off the bacteria that cause urinary tract infections.
Why COVID-19 vaccine distribution methods fall short and 3 ways to improve them
Several proposals have emerged on how to distribute the COVID-19 vaccine, but they fall short in ensuring that the vaccine is distributed fairly. A team including Binghamton University professor Nicole Hassoun suggests three ways to more fairly and effectively distribute the vaccine so that people in poor countries get the vaccine as soon as possible.
There is no data indicating that the COVID-19 is unsafe for pregnant women.
Pregnant women are at increased risk of severe COVID-19. Also, many women of childbearing age have increased COVID-19 exposure risks, including healthcare providers and other workers providing essential services.
SHRO Professor to Discuss Russia’s COVID-19 Vaccine in Virtual Event with Columbia University Harriman Institute
The panel of experts will discuss recent trials that have demonstrated efficacy for the vaccine, despite an early release in August 2020 which was met with skepticism by the international community.
COVID-19 VACCINE ACCEPTANCE FALLING GLOBALLY AND IN THE U.S., SURVEY FINDS
The percentage of people globally who say they will get a COVID-19 vaccine has fallen in recent weeks, even as tens of millions of doses have been administered around the world, new survey data suggest.
Flu vaccination this season likely to be highest ever
More U.S. adults reported receiving or planning to receive an influenza vaccination during the 2020-2021 flu season than ever before, according to findings from a December 2020 national survey.
Global Vaccine Symposium Press Conference
Press conference will discuss COVID-19 vaccine research, development, rollout in conjunction with the COVID-19 Vaccine Development, Strategy and Implementation Virtual Global Health Symposium, organized by Columbia University, running from 22-26 February
Vaccine Prioritization Dashboard Launches @JohnsHopkins for People with Disabilities
A new Johns Hopkins data tool helps people with disabilities determine when they qualify for the COVID-19 vaccine and compares how different states prioritize the disability community in the vaccine rollout.
Created by researchers, students and advocates who themselves are disabled and have personally experienced how inequitable and inaccessible the pandemic response has been, the COVID-19 Vaccine Prioritization Dashboard launched to not only help the disability community get vaccinated, but also to arm policymakers with data to improve the system.
Cancer Organizations Urge Priority Access to COVID-19 Vaccine for Cancer Patients, Survivors
130 cancer centers and other cancer organizations sent a letter to President Joseph R. Biden, key members of his administration, and leading state public health officials to strongly encourage prioritizing patients with cancer and survivors of cancer when administering lifesaving COVID-19 vaccines.
It’s morally wrong for rich nations to hoard COVID-19 vaccine
Rich nations should not engage in “vaccine nationalism” and keep the COVID-19 vaccine to themselves when poorer nations need them, according to Nicole Hassoun, professor of philosophy at Binghamton University, State University of New York.
Systemic Racism & Health Care: Building Black Confidence in the COVID-19 Vaccine
The Tuskegee syphilis experiment. The secret sale of Henrietta Lacks cancer research cells. Jim Crow laws affecting African Americans’ ability to receive medical treatment. For weeks, it’s been hard to hear over the clamor of millions of Americans lining up for COVID-19 vaccines. But not everyone has been enthused — namely, large swaths of minority communities, which comprise the populations disproportionately impacted by the virus, but whose hesitance is largely fueled by the country’s racist medical past.
Where Black Americans Will Travel Farther than Whites for COVID-19 Vaccination
Similar to the idea of “food deserts,” many urban Black neighborhoods lack pharmacies, clinics, hospitals or health centers that can administer COVID-19 vaccines. The analysis, including a detailed facility map, points to the places where there is a need for temporary mass vaccination sites.
Research finds people diagnosed with HIV in New York State were more than twice as likely to die from COVID-19
New research out of the University at Albany and the AIDS Institute at the New York State Department of Health found that through the middle of 2020, people diagnosed with HIV infection were significantly more likely to contract, be hospitalized with and die from COVID-19.
Business experts are available to comment on the challenges of COVID-19 vaccine shortages, distribution, and demand.
INDIANAPOLIS and BLOOMINGTON, Ind. — Alleviating the coronavirus pandemic rests on worldwide vaccination efforts, but many countries are reporting dwindling supplies of the COVID-19 vaccine. At the same time, the Biden administration aims to buy 200 million more doses, to…
Pharmacies to play major role in distributing COVID-19 vaccine, sharing information
Your corner pharmacy will play a big role in delivering the COVID-19 vaccine and sharing important info with the public, according to Sarah Lynch, clinical assistant professor of pharmacy practice at Binghamton University, State University of New York. A key…
Story Tips from Johns Hopkins Experts on COVID-19
Vaccines take time to work. After getting a COVID-19 vaccine, it takes a while for the immune system to fully respond and provide protection from the virus. For the Moderna and Pfizer COVID-19 vaccines, it takes up to two weeks after the second shot to become appropriately protected.
Johns Hopkins Medicine Hosts Briefing on COVID-19: One Year Later
A Woman’s Journey will host a 90-minute virtual event, “COVID-19: One Year Later,” during which Johns Hopkins Medicine experts will address important issues related to COVID-19 such as new and available treatments and vaccine safety and efficacy. Registrants will learn about the continued urgency of public health measures to mitigate the pandemic despite the introduction of vaccines, what distinguishes the leading vaccine contenders in their methodology, safety and effectiveness, and symptoms and insights surrounding lingering deficits in physical function, mental health and cognition among COVID-19 survivors.
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
Israel’s Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.
AACI Partners With Federal Vaccine Panel to Promote Cancer Patient Health
AACI was invited last summer to join the Vaccine Consultation Panel (VCP) alongside other leading health and science organizations in the U.S. Through the VCP, AACI has received periodic updates on the development and distribution of COVID-19 vaccines and participated in efforts to educate the cancer center community and the general public on the importance of widespread vaccine uptake.
Healthy sleep and immune response to COVID-19 vaccination
Healthy sleep is integral to a strong immune system, and as COVID-19 vaccines are distributed, it’s important that people continue to get sufficient sleep for optimal immune response. Sleep loss is associated with changes in several immune processes. Poor sleep…
ACAAI Provides Further Guidance on Risk of Allergic Reactions to mRNA COVID-19 Vaccines
Updated guidance includes questions for those being vaccinated regarding previous allergic reactions.
Pharmacists will play major role in COVID-19 vaccinations, but it will be challenging
Pharmacists will play an important role in issuing the COVID-19 vaccine to the public, but that comes with challenges, said Sarah Lynch, clinical assistant professor of pharmacy practice at Binghamton University, State University of New York. “Pharmacists have been playing…
COVID-19 model compares effectiveness of vaccine and mitigation strategies
Predicting the spread of COVID-19 using standard statistical models has its challenges, which is why two Iowa State University researchers developed a network-based approach to look at the impact of specific policies and vaccination strategies throughout the many stages of the pandemic.
TTP El Paso Receives 3,000 doses of Moderna’s COVID-19 Vaccine
Three thousand doses of Moderna’s COVID-19 vaccine arrived at the Texas Tech Physicians of El Paso Alberta, Kenworthy and Transmountain clinics on Wednesday, Dec. 23.